Open AccessA Comparative Study of Efficacy and Safety of Agomelatine and Escitalopram in Major Depressive Disorder
Author(s) -
Ravi Babu Komaram,
Srikrishukala,
Jayasree Palla,
Lakshmana Rao Nambaru,
Satyanarayana Murthy Kasturi
Publication year - 2015
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2015/12371.6092
Subject(s) - escitalopram , agomelatine , major depressive disorder , hamilton rating scale for depression , clinical global impression , medicine , psychology , rating scale , mood , psychiatry , antidepressant , depression (economics) , anxiety , developmental psychology , alternative medicine , macroeconomics , pathology , economics , placebo
Major depressive disorder (MDD) is a mental disorder characterized by episodes of depressed mood, loss of interest or pleasure, feeling of guilt or low self-esteem, loss of energy, altered sleep patterns and difficulty in concentration.